Charles Cant
Max Planck Society
1 Papers
Charles Cant is an academic researcher from Max Planck Society. The author has contributed to research in topics: Fusion protein & Cell–cell interaction. The author has an hindex of 1, co-authored 1 publications. Previous affiliations of Charles Cant include University of California, San Francisco & University of Tübingen.
Chat about Author
Papers
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.
Martina Seiffert,Charles Cant,Charles Cant,Charles Cant,Zhengjun Chen,Zhengjun Chen,Zhengjun Chen,Irene Rappold,Irene Rappold,Irene Rappold,Brugger W,Brugger W,Brugger W,Kanz L,Kanz L,Kanz L,Eric J. Brown,Eric J. Brown,Eric J. Brown,Axel Ullrich,Axel Ullrich,Axel Ullrich,Hans-Jörg Bühring,Hans-Jörg Bühring,Hans-Jörg Bühring +24 more
TL;DR: CD47 is identified as the extracellular ligand for human SIRP and it is shown that these two counterreceptors are involved in cellular adhesion.
311